Skip to main content
. 2023 Feb 2;9:40. doi: 10.1038/s41420-023-01315-2

Fig. 1. CRISPR/Cas9 screening identifies CDC7 as a potential synergistic target for chemo-resistant SCLC.

Fig. 1

A Schematic of the screening process using resistant SCLC cells H69-AR with GeCKOv2 library. B Volcano plot of differentially enriched sgRNAs between negative treatment and chemo-treatment. C Workflow of potential synergistic targets identification. D Expression of CDC7 in SCLC and normal tissues from GSE43346. Independent sample t-test were used to examine statistical significance. *p < 0.05, **p < 0.01, ***p < 0.001.